PRESS RELEASE published on 11/24/2025 at 07:00, 1 month ago Sandoz launches Afqlir® (aflibercept) in Europe, providing affordable treatment option for patients with retinal diseases Sandoz launches Afqlir® (aflibercept) in Europe, providing affordable treatment option for patients with retinal diseases. Afqlir® matches reference medicine in efficacy, safety, and pharmacokinetics, reinforcing Sandoz commitment to patient access Retinal Diseases Sandoz Aflibercept Afqlir European Launch
PRESS RELEASE published on 11/24/2025 at 07:00, 1 month ago MPC Capital reports strong results for first nine months of 2025, forecast confirmed MPC Capital reports strong results for first nine months of 2025, guidance confirmed. Recurring management fees up 5%, earnings per share rise by 37% year-on-year Earnings Per Share Guidance MPC Capital Results 9-month Figures
REGULATED PRESS RELEASE published on 11/24/2025 at 07:00, 1 month ago Entry into exclusive negotiations for Novacel Compagnie Chargeurs Invest in exclusive negotiations with KPS Capital Partners for the sale of controlling stake in Novacel, aiming to strengthen equity and support growth Exclusive Negotiations Sale KPS Capital Partners Novacel Compagnie Chargeurs Invest
PRESS RELEASE published on 11/24/2025 at 07:00, 1 month ago BNP PARIBAS LAUNCHES A SHARE BUYBACK PROGRAMME OF EUR 1.15 BILLION FOR THE 2025 FINANCIAL YEAR RESULTS BNP Paribas launches a share buyback program of EUR 1.15 billion for the 2025 financial year results. The program follows approval from the European Central Bank, aims to repurchase shares for various purposes as outlined in the press release BNP Paribas Share Buyback Program European Central Bank 2025 Financial Year EUR 1.15 Billion
PRESS RELEASE published on 11/24/2025 at 06:59, 1 month ago Medartis appoints Peter Hackel as new Chief Financial Officer Medartis appoints Peter Hackel as new Chief Financial Officer effective 1 January 2026. Dr Dirk Kirsten, current CFO, to conclude service after transition. Hackel has strong financial leadership experience in growth-oriented companies CFO Financial Leadership Medartis Peter Hackel Orthopaedic Company
PRESS RELEASE published on 11/24/2025 at 06:30, 1 month ago Victoria McLean to become Chief Compliance Officer of Julius Baer and join the Executive Board Julius Baer appoints Victoria McLean as Chief Compliance Officer & Executive Board member. McLean brings 30 years of wealth management expertise from Goldman Sachs Wealth Management Executive Board Julius Baer Chief Compliance Officer Victoria McLean
PRESS RELEASE published on 11/24/2025 at 06:30, 1 month ago NTC becomes commercialization partner for Formycon’s Eylea® biosimilar FYB203/Baiama® in Italy Formycon AG partners with NTC for Eylea biosimilar commercialization in Italy. Agreement includes royalties and supply chain organization Italy Formycon AG Commercialization Eylea Biosimilar NTC
PRESS RELEASE published on 11/24/2025 at 06:29, 1 month ago Rieter with New Group Structure Ad-hoc announcement pursuant to Art. 53 LR Rieter AG announces new group structure in ad-hoc announcement, impacting company personnel. Contact for more info Ad-hoc Announcement Group Structure Personnel Rieter AG Restructure
PRESS RELEASE published on 11/23/2025 at 23:46, 1 month ago Hans-Joachim Watzke resigns as managing director of Borussia Dortmund Geschäftsführungs-GmbH and is elected president of Ballspielverein Borussia 09 e.V. Dortmund Hans-Joachim Watzke resigns as managing director of Borussia Dortmund Geschäftsführungs-GmbH and is elected president of Ballspielverein Borussia 09 e.V. Dortmund Managing Director President Borussia Dortmund Hans-Joachim Watzke Resigns
PRESS RELEASE published on 11/23/2025 at 16:47, 1 month 1 day ago EQS-Adhoc: Bayer Aktiengesellschaft: Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention Bayer announces positive results from Phase III OCEANIC-STROKE study, showing asundexian reduces ischemic stroke risk with antiplatelet therapy Bayer Antiplatelet Therapy Asundexian OCEANIC-STROKE Study Ischemic Stroke
Published on 12/24/2025 at 15:25, 4 hours 18 minutes ago CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
Published on 12/24/2025 at 14:00, 5 hours 43 minutes ago Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
Published on 12/24/2025 at 14:00, 5 hours 43 minutes ago Alta Copper Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders and Optionholders to be Held on January 26, 2026
Published on 12/24/2025 at 05:00, 14 hours 43 minutes ago Alphinat Inc. and the Hague Conference on Private International Law (HCCH) Today Announced the Launch of the New e-Country Profile Platform
Published on 12/24/2025 at 16:30, 3 hours 12 minutes ago ABB Ltd: ABB share buybacks - December 18, 2025 - December 23, 2025
Published on 12/24/2025 at 15:07, 4 hours 35 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/24/2025 at 15:06, 4 hours 36 minutes ago Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 12/24/2025 at 15:06, 4 hours 36 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 12/24/2025 at 15:05, 4 hours 37 minutes ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Published on 12/22/2025 at 18:05, 2 days 1 hour ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 17:35, 2 days 2 hours ago DISCLOSURE OF TRANSACTIONS IN OWN SHARES FROM DECEMBER 15 TO DECEMBER 19, 2025
Published on 12/22/2025 at 15:00, 2 days 4 hours ago Capital increase through exercise of subscription rights
Published on 12/22/2025 at 09:18, 2 days 10 hours ago GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 11/12/2025